Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Chizhik opened its first stores in the Rostov region and Krasnodar Krai

8/15/23 -

Ministry of Finance supported payment of dividends by Rostelecom

8/15/23 RTKM

DA! discounters' revenue for 6 months of 2023 grew 19.2%

8/15/23 OKEY

X5 Retail Group reported for 6 months of 2023

8/15/23 -

Kamaz expects sales of heavy trucks to grow by 60%

8/15/23 KMAZ

SFI has suspended selling into the stock market from the balance sheet

8/14/23 SFIN

Samolet reported for 6 months of 2023 by RAS

8/14/23 SMLT

Harmony Biosciences buys Zynerba Pharmaceuticals

8/14/23 ZYNE

Slavneft-Megionneftegaz reported for 6 months of 2023 by RAS

8/14/23 MFGS

Gazprom Neft produces an Arctic shelf of 25 million tons of oil

8/14/23 SIBN